Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?

Zeeshan Mansuri; Mahwish Adnan; Bhumika Shah; Chintan Trivedi; Ramu Vadukapuram; Shweta Patel; Garima Yadav; Sushma Srinivas; Maliha Ansari; Ramkrishna Makani; Raman Baweja; Abhishek Reddy

doi:10.1097/JCP.0000000000001812

Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?

Zeeshan Mansuri
, Mahwish Adnan
, Bhumika Shah
, Chintan Trivedi
, Ramu Vadukapuram
, Shweta Patel
, Garima Yadav
, Sushma Srinivas
, Maliha Ansari
, Ramkrishna Makani
, Raman Baweja
, Abhishek Reddy

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	199-200
Number of pages	2
Journal	Journal of Clinical Psychopharmacology
Volume	44
Issue number	2
DOIs	https://doi.org/10.1097/JCP.0000000000001812
State	Published - Mar 1 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1097/JCP.0000000000001812

Cite this

Mansuri, Z., Adnan, M., Shah, B., Trivedi, C., Vadukapuram, R., Patel, S., Yadav, G., Srinivas, S., Ansari, M., Makani, R., Baweja, R., & Reddy, A. (2024). Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning? Journal of Clinical Psychopharmacology, 44(2), 199-200. https://doi.org/10.1097/JCP.0000000000001812

@article{83189fd763544f4aa05c1901fe1cc0f5,

title = "Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?",

author = "Zeeshan Mansuri and Mahwish Adnan and Bhumika Shah and Chintan Trivedi and Ramu Vadukapuram and Shweta Patel and Garima Yadav and Sushma Srinivas and Maliha Ansari and Ramkrishna Makani and Raman Baweja and Abhishek Reddy",

year = "2024",

month = mar,

day = "1",

doi = "10.1097/JCP.0000000000001812",

language = "English (US)",

volume = "44",

pages = "199--200",

journal = "Journal of Clinical Psychopharmacology",

issn = "0271-0749",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

Mansuri, Z, Adnan, M, Shah, B, Trivedi, C, Vadukapuram, R, Patel, S, Yadav, G, Srinivas, S, Ansari, M, Makani, R, Baweja, R & Reddy, A 2024, 'Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?', Journal of Clinical Psychopharmacology, vol. 44, no. 2, pp. 199-200. https://doi.org/10.1097/JCP.0000000000001812

TY - JOUR

T1 - Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications

T2 - Is It Time to Revisit FDA Warning?

AU - Mansuri, Zeeshan

AU - Adnan, Mahwish

AU - Shah, Bhumika

AU - Trivedi, Chintan

AU - Vadukapuram, Ramu

AU - Patel, Shweta

AU - Yadav, Garima

AU - Srinivas, Sushma

AU - Ansari, Maliha

AU - Makani, Ramkrishna

AU - Baweja, Raman

AU - Reddy, Abhishek

PY - 2024/3/1

Y1 - 2024/3/1

UR - https://www.scopus.com/pages/publications/85186554736

UR - https://www.scopus.com/pages/publications/85186554736#tab=citedBy

U2 - 10.1097/JCP.0000000000001812

DO - 10.1097/JCP.0000000000001812

M3 - Letter

C2 - 38227629

AN - SCOPUS:85186554736

SN - 0271-0749

VL - 44

SP - 199

EP - 200

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

IS - 2

ER -

Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this